
Beringea exits APM Healthcare
APM Healthcare, which is part owned by UK growth capital investor Beringea, has been bought by national pharmacy chain Day Lewis Pharmacy.
The deal generated a 3x return for Beringea. Day Lewis will take over APM's 18 UK pharmacies, which it runs in joint venture partnerships with GP Practices.
Beringea first invested in APM in 2011 when it had just one pharmacy. Follow-up investments lifted its total amount invested to £2m, which includes both debt and equity.
Beringea invested using its Proven Growth and Income venture capital trust, and kept a minority stake in the company. The majority of the company was owned by director Andrew Murray.
In the year to April 2016, the company made profit before tax of £228,813 according to publicly available documents.
Company
Founded in 2009, APM is an independent consultancy that works in partnership with GP practices, primary care premises developers and pharmacy owners. It focuses on improving incomes and ensuring the requirements of various regulatory bodies, such as the CQC and GPhC, are met. Its operations are based in the UK.
People
Beringea – Steven Tuckley (chief financial officer).
APM Healthcare – Andrew Murray (managing director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater